ONLINE DATABASE SEARCH -
HIV-LS-366-MEMO
1.
59950 HIV-LS-366;
EMBASE-HIV-1/21/2007
Inhibition of HIV-1 infection by synthetic peptides derived CCR5
fragments
Imai, Masaki, Baranyi, Lajos, Okada, Noriko, and Okada,
Hidechika
Biochemical and Biophysical Research Communications 2007. 353(4): 851-856
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6WBK-4MMFRH8-2/2/b882e26891c7ee211710ebf48b2223d7
2.
59951 HIV-LS-366;
PUBMED-HIV-1/22/2007
Non-nucleoside reverse transcriptase inhibitors: a review
Waters, L, John, L, and Nelson, M
Int J Clin Pract 2007.
61(1): 105-18
View Data on the NIAID Therapeutics Website
HYPERLINK:
3.
59952 HIV-LS-366;
EMBASE-HIV-1/21/2007
Discovery of small-molecule HIV-1 fusion and integrase inhibitors
oleuropein and hydroxytyrosol: II. Integrase inhibition
Lee-Huang, Sylvia, Huang, Philip Lin, Zhang, Dawei, Lee, Jae Wook, Bao,
Ju, Sun, Yongtao, Chang, Young-Tae, Zhang, John, and Huang, Paul
Lee
Biochemical and Biophysical Research Communications 2007. In Press, Uncorrected Proof:
180
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6WBK-4MW8XVH-1/2/208a2cd3182149ac9d79d450980fb590
4.
59953 HIV-LS-366;
EMBASE-HIV-1/21/2007
Discovery of novel benzimidazolones as potent non-nucleoside reverse
transcriptase inhibitors active against wild-type and mutant HIV-1
strains
Barreca, Maria Letizia, Rao, Angela, Luca, Laura De, Iraci, Nunzio,
Monforte, Anna-Maria, Maga, Giovanni, Clercq, Erik De, Pannecouque, Christophe,
Balzarini, Jan, and Chimirri, Alba
Bioorganic & Medicinal Chemistry Letters 2007. In Press, Accepted Manuscript:
180
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6TF9-4MVN0XT-8/2/7a62c6d501cc914fa534e1e5e7f023d1
5.
59954 HIV-LS-366;
EMBASE-HIV-1/21/2007
Ring substituent effects on biological activity of vinyl sulfones as
inhibitors of HIV-1
Meadows, DChristopher, Sanchez, Tino, Neamati, Nouri, North, Thomas W,
and Gervay-Hague, Jacquelyn
Bioorganic & Medicinal Chemistry 2007. 15(2): 1127-1137
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6TF8-4M3R29H-7/2/76b51f269c645300917d3a9af78ee93b
6.
59955 HIV-LS-366;
EMBASE-HIV-1/21/2007
Development of a one-step immunochromatographic strip test for the rapid
detection of nevirapine (NVP), a commonly used antiretroviral drug for the
treatment of HIV/AIDS
Pattarawarapan, M, Nangola, S, Cressey, TR, and Tayapiwatana,
C
Talanta 2007. 71(1):
462-470
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6THP-4K9C6DY-2/2/345a53399eb565d81f962077e6a2c408
7.
59956 HIV-LS-366;
EMBASE-HIV-1/21/2007
HIV1 protease inhibitors selectively induce inflammatory chemokine
expression in primary human osteoblasts
Malizia, Andrea P, Vioreanu, Mihai H, Doran, Peter P, and Powderly,
William G
Antiviral Research 2007.
In Press, Uncorrected Proof: 309
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6T2H-4MSJNJY-1/2/0bb713819591d1148865967d41337441
8.
59957 HIV-LS-366;
PUBMED-HIV-1/22/2007
A broad antiviral neutral glycolipid, fattiviracin FV-8, is a membrane
fluidity modulator
Harada, S, Yokomizo, K, Monde, K, Maeda, Y, and Yusa,
K
Cell Microbiol
2007. 9(1):
196-203
View Data on the NIAID Therapeutics Website
HYPERLINK:
9.
59958 HIV-LS-366;
PUBMED-HIV-1/22/2007
N88D
Facilitates the Co-occurrence of D30N and L90M and the Development of Multidrug
Resistance in HIV Type 1 Protease following Nelfinavir Treatment
Failure
Mitsuya, Y, Winters, MA, Fessel, WJ, Rhee, SY, Hurley, L, Horberg, M,
Schiffer, CA, Zolopa, AR, and Shafer, RW
AIDS Res Hum Retroviruses 2006. 22(12): 1300-5
View Data on the NIAID Therapeutics Website
HYPERLINK:
10.
59959 HIV-LS-366;
PUBMED-HIV-1/22/2007
Drug interactions. Brecanavir--a new protease inhibitor
Anon
TreatmentUpdate 2006.
18(3): 6-7
View Data on the NIAID Therapeutics Website
HYPERLINK:
11.
59960 HIV-LS-366;
PUBMED-HIV-1/22/2007
Inhibition of HIV-1 infection by viral chemokine U83A via high affinity
CCR5 interactions which block human chemokine-induced leukocyte chemotaxis and
receptor internalisation
Catusse, J, Parry, CM, Dewin, DR, and Gompels, UA
Blood 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
12.
59961 HIV-LS-366;
PUBMED-HIV-1/22/2007
Modulation of human BCRP (ABCG2) activity by anti-HIV
drugs
Weiss, J, Rose, J, Storch, CH, Ketabi-Kiyanvash, N, Sauer, A, Haefeli,
WE, and Efferth, T
J Antimicrob Chemother 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
13.
59962 HIV-LS-366;
PUBMED-HIV-1/22/2007
Non-nucleoside reverse transcriptase inhibitors (NNRTIs): past, present,
and future
De Clercq, E
Chem Biodivers 2004.
1(1): 44-64
View Data on the NIAID Therapeutics Website
HYPERLINK:
14.
59963 HIV-LS-366;
PUBMED-HIV-1/22/2007
Antibodies against a multiple-peptide conjugate comprising chemically
modified human immunodeficiency virus type-1 functional Tat peptides inhibit
infection
Devadas, K, Boykins, RA, Hewlett, IK, Wood, OL, Clouse, KA, Yamada, KM,
and Dhawan, S
Peptides 2006.
View Data on the NIAID Therapeutics Website
HYPERLINK:
15.
59964 HIV-LS-366;
WOS-HIV-1/15/2007
Halichondria sulfonic acid, a new HIV-1 inhibitory guanidino-sulflonic
acid, and halistanol sulfate isolated from the marine sponge Halichondria rugosa
Ridley & Dendy
Jin, Y, Fotso, S, Yongtang, Z, Sevvana, M, Laatsch, H, and Zhang,
W
NATURAL PRODUCT RESEARCH 2006. 20(12): 1129-1135,
7
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000242898600016
16.
59965 HIV-LS-366;
WOS-HIV-1/15/2007
Inhibitors of the chemokine receptor CXCR4: Chemotherapy of AIDS,
metastatic cancer, leukemia and rheumatoid arthritis
Tsutsumi, H, Tamamura, H, and Fujii, N
LETTERS IN DRUG DESIGN & DISCOVERY 2007. 4(1): 20-26, 7
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000242910300004
17.
59966 HIV-LS-366;
WOS-HIV-1/15/2007
Downregulation of CCR5 expression on cells by recombinant adenovirus
containing antisense CCR5, a possible measure to prevent HIV-1 from entering
target cells
Li, WG, Yu, M, Bai, L, Bu, DF, and Xu, XY
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 2006. 43(5): 516-522, 7
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000242793600003
18.
59967 HIV-LS-366;
WOS-HIV-1/15/2007
Identification of a novel circulating recombinant form (CRF33_01B)
disseminating widely among various risk populations in Kuala Lumpur,
Malaysia
Tee, KK, Li, XJ, Nohtomi, K, Ng, KP, Kamarulzaman, A, and Takebe,
Y
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 2006. 43(5): 523-529, 7
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000242793600004
19.
59968 HIV-LS-366;
WOS-HIV-1/15/2007
Metabolism and disposition studies of potent HIV integrase inhibitors
using 19F NMR
Monteagudo, E, Pesci, S, Taliani, M, Fonsi, M, Verdirame, M, Naimo, F,
Bonelli, F, Di Marco, A, Fiore, F, Gonzalez-Paz, O, Summa, V, Rowley, M, and
Laufer, R
DRUG METABOLISM REVIEWS 2006. 38: 160-161, 2
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239659200244
20.
59969 HIV-LS-366;
WOS-HIV-1/15/2007
Activity of HIV entry and fusion inhibitors expressed by the human
vaginal colonizing probiotic Lactobacillus reuteri RC-14
Liu, JJ, Reid, G, Jiang, YH, Turner, MS, and Tsai,
CC
CELLULAR MICROBIOLOGY 2007.
9(1): 120-130, 11
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000242780900011
21.
59970 HIV-LS-366;
WOS-HIV-1/15/2007
Synthesis of styrylquinoline carboxamides for HIV-1 integrase
inhibitors
Lee, SU, Park, JH, Lee, JY, Shin, CG, Chung, BY, and Lee,
YS
BULLETIN OF THE KOREAN CHEMICAL SOCIETY 2006. 27(11): 1888-1890,
3
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000242822500034
22.
59971 HIV-LS-366;
WOS-HIV-1/21/2007
New derivatives of alkyl- and aminocarbonylphosphonic acids containing 3
'-azido-3 '-deoxythymidine
Jasko, MV, Shipitsyn, AV, Khandazhinskaya, AL, Shirokova, EA, Sol'yev,
PN, Plyasunova, OA, and Pokrovskii, AG
RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY 2006. 32(6): 542-546, 5
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000242884000005
23.
59972 HIV-LS-366;
WOS-HIV-1/21/2007
Nuclear Factor 90, a cellular dsRNA binding protein inhibits the HIV
Rev-export function
Urcuqui-Inchima, S, Castano, ME, Hernandez-Verdun, D, St-Laurent, G, and
Kumar, A
RETROVIROLOGY 2006.
3: 13
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243003700001
24.
59973 HIV-LS-366;
WOS-HIV-1/21/2007
Release of autoinhibition converts ESCRT-III components into potent
inhibitors of HIV-1 budding
Zamborlini, A, Usami, Y, Radoshitzky, SR, Popova, E, Palu, G, and
Gottlinger, H
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
AMERICA 2006. 103(50):
19140-19145, 6
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000242884200048
25.
59974 HIV-LS-366;
WOS-HIV-1/21/2007
Identification of novel non-nucleoside reverse transcriptase inhibitors
using fragment-based lead generation
Ramajayam, R, Giridhar, R, Yadav, MR, De Clereq, E, Pannecouque, C, and
Prajapati, DG
MEDICINAL CHEMISTRY RESEARCH 2005. 14(8-9): 475-487,
13
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243027900004
26.
59975 HIV-LS-366;
WOS-HIV-1/21/2007
Pradimicin A, a carbohydrate-binding nonpeptidic lead compound for
treatment of infections with viruses with highly glycosylated envelopes, such as
human immunodeficiency virus
Balzarini, J, Van Laethem, K, Daelemans, D, Hatse, S, Bugatti, A,
Rusnati, M, Igarashi, Y, Oki, T, and Schols, D
JOURNAL OF VIROLOGY 2007.
81(1): 362-373, 12
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000242958600033
27.
59976 HIV-LS-366;
WOS-HIV-1/21/2007
Modulation of specific surface receptors and activation sensitization in
primary resting CD4(+) T lymphocytes by the Nef protein of HIV-1
Keppler, OT, Tibroni, N, Venzke, S, Rauch, S, and Fackler,
OT
JOURNAL OF LEUKOCYTE BIOLOGY 2006. 79(3): 616-627, 12
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243015000021
28.
59977 HIV-LS-366;
WOS-HIV-1/21/2007
Inhibition of HIV-1 replication by RNA interference of p53
expression
Pauls, E, Senserrich, J, Clotet, B, and Este, JA
JOURNAL OF LEUKOCYTE BIOLOGY 2006. 80(3): 659-667, 9
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243015700024
29.
59978 HIV-LS-366;
WOS-HIV-1/21/2007
Mechanisms underlying activity of antiretroviral drugs in HIV-1-infected
macrophages: new therapeutic strategies
Aquaro, S, Svicher, V, Schols, D, Pollicita, M, Antinori, A, Balzarini,
J, and Perno, CF
JOURNAL OF LEUKOCYTE
BIOLOGY 2006. 80(5):
1103-1110, 8
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243016100015